- Recent Funding
- Investors
- Centre for Commercialization of Cancer Immunotherapy
Centre for Commercialization of Cancer Immunotherapy portfolio
Centre for Commercialization of Cancer Immunotherapy has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Triumvira Immunologics's $55M Series A round in August 2020, alongside Leaps by Bayer, Oceanpine Capital, Viva Biotech and 2 others. That company is in Health and bio.
What Centre for Commercialization of Cancer Immunotherapy invests in
- Health and bio · 1 · 100%
How Centre for Commercialization of Cancer Immunotherapy invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $55M |
Centre for Commercialization of Cancer Immunotherapy portfolio companies
TTriumvira Immunologics$55MSeries A · Aug 2020
| Company | Round with Centre for Commercialization of Cancer Immunotherapy | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $55M | $100M | Mar 17, 2022 Series A |
Most frequent co-investors
LLeaps by Bayer1 shared round · last Aug 1, 2020
NNorthpond Ventures1 shared round · last Aug 1, 2020
OOceanpine Capital1 shared round · last Aug 1, 2020
- VViva Biotech1 shared round · last Aug 1, 2020
BBloom Burton & Co.1 shared round · last Aug 1, 2020
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Centre for Commercialization of Cancer Immunotherapy. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Centre for Commercialization of Cancer Immunotherapy, which is a subset of its real portfolio. API: /api/v1/investors/centre-for-commercialization-of-cancer-immunotherapy (get a free API key). More: the most active VC firms and new venture capital funds.